3 Small-Cap Stocks With Huge Growth Potential

Given their solid growth potential and attractive valuations, these three small-cap stocks would be excellent buys for long-term investors.

| More on:

Small-cap companies have their market capitalization between $300 million and $2 billion. These companies possess higher-growth potential and have the potential to deliver solid returns in the long run. However, these companies can be highly volatile and vulnerable to market volatility. So, given their volatile nature, investors with higher risk-taking abilities can invest in them. Meanwhile, here are my three top picks.

goeasy

goeasy (TSX:GSY), which provides leasing and lending services to sub-prime customers, is my first pick. It has grown its financials at a healthy rate over the last 20 years, with its adjusted net income growing at a CAGR of 31%. Despite its impressive growth, the company has acquired just 3% of its addressable market, thus providing a substantial growth potential.

With the improvement in economic activities amid the easing of COVID-related restrictions, loan originations have increased, benefiting goeasy. Meanwhile, the company is focusing on strengthening its omnichannel lending services, venturing into new markets, increasing its penetration in key geographic markets, and improving customer experience to expand its market share.

Notably, the company has set optimistic guidance for the next three years, with its loan portfolio projected to grow 67% to reach $3.6 billion by 2026.

Despite its healthy growth potential, goeasy trades at an attractive NTM price-to-earnings multiple of 7.9. It is also growing its dividend at a CAGR of 34% since 2014. Considering all these factors, I am bullish on goeasy.

WELL Health Technologies

WELL Health Technologies (TSX:WELL) is a digital healthcare company that facilitates healthcare professionals in providing omnichannel solutions. Meanwhile, given their convenience and accessibility, telehealthcare services are becoming popular, thus driving the demand for the company’s services.

Meanwhile, WELL Health had recently announced to ramp up its M&A activities. Last month, it signed an agreement to acquire INLIV, a premium omnichannel primary care provider. The acquisition could allow the company to expand its footprint in Alberta. Additionally, the company has strengthened its presence in the United States by acquiring Circle Medical and Wisp. The combined revenue from both companies has crossed $110 million in annualized run rate. So, its growth prospects look healthy.

However, amid the weakness in growth stocks, WELL Health has lost around 65% of its stock value compared to its 52-week highs. The correction has dragged its NTM price-to-earnings multiple down to an attractive 14.5. So, given its high-growth prospects and attractive valuation, I expect WELL Health to deliver multi-fold returns in the long run.

Docebo

Docebo (TSX:DCBO)(NASDAQ:DCBO), which offers corporate e-learning solutions, is my final pick. Amid the increased adoption of hybrid work culture and remote learning, the demand for e-learning solutions is rising. Meanwhile, Fosway Group projects the LMS (learning management system) market to grow at a CAGR of 21% from 2019 to 2025.

Docebo’s growing customer base, increasing average contract value, and multi-year agreements with clients could support its growth in the coming years. Meanwhile, it also earns over 90% of its revenue from recurring sources, which is encouraging. Despite its healthy growth potential, Docebo has lost over 65% of its stock value compared to its 52-week high. So, given its high growth potential, I believe investors should utilize the steep pullback to accumulate the stock to earn solid returns over the next 10 years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Docebo Inc. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Investing

Train cars pass over trestle bridge in the mountains
Dividend Stocks

Is CNR Stock a Buy, Sell, or Hold for 2025?

Can CNR stock continue its long-term outperformance into 2025 and beyond? Let's explore whether now is a good time to…

Read more »

engineer at wind farm
Energy Stocks

Invest $20,000 in This Dividend Stock for $100 in Monthly Passive Income

This dividend stock has it all – a strong outlook, monthly income, and even more to consider buying today.

Read more »

Hourglass and stock price chart
Stock Market

It’s Not Too Late: Invest in These TSX Growth Stocks Now

Solid fundamentals of these top TSX growth stocks could help them maintain strong upward momentum in the years to come.

Read more »

coins jump into piggy bank
Dividend Stocks

The Smartest Dividend Stocks to Buy With $500 Right Now

These top dividend stocks both offer attractive yields and trade off their highs, making them two of the best to…

Read more »

stocks climbing green bull market
Stocks for Beginners

3 TSX Stocks Soaring Higher With No Signs of Slowing

Don't ignore stocks just because they look like they're at a high price. Instead, see exactly why they've driven so…

Read more »

dividends can compound over time
Bank Stocks

Is TD Bank Stock a Buy for Its 5.2% Dividend Yield?

TD Bank stock offers a rare 5.2% dividend yield—can it rebound from challenges and reward contrarian investors? Here's what to…

Read more »

chart reflected in eyeglass lenses
Investing

How Should a Beginner Invest in Stocks? Start With This Index Fund

This Vanguard index fund is the perfect way to start a Canadian investment portfolio.

Read more »

analyze data
Bank Stocks

Is BMO Stock a Buy for its 4.7% Dividend Yield?

Bank of Montreal is up 20% since late August. Are more gains on the way?

Read more »